{
    "title": "FDA declines to authorize common antidepressant as COVID treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10822597/FDA-declines-authorize-common-antidepressant-COVID-treatment.html",
    "date": "2022-05-16",
    "keywords": [
        "drug",
        "fda",
        "boulware",
        "fluvoxamine",
        "leo",
        "erman",
        "data",
        "covid19",
        "emergency",
        "request",
        "paxlovid",
        "covid",
        "everyone",
        "access",
        "study",
        "standard",
        "food",
        "administration",
        "therapeutic",
        "virus",
        "review",
        "evidence",
        "treatment",
        "progression",
        "disease",
        "andor",
        "hospitalization",
        "agency",
        "document",
        "httpswwwaccessdatafdagovdrugsatfda_docsnda2020eua2011020fluvoxamine20decisional20memo_redactedpdf",
        "university",
        "minnesota",
        "professor",
        "dr",
        "david",
        "use",
        "authorization",
        "maleate",
        "class",
        "serotonin",
        "reuptake",
        "ssris",
        "availability",
        "pfizer",
        "incs",
        "interview",
        "world",
        "low",
        "middleincome",
        "submission",
        "brazil",
        "endpoint",
        "drop",
        "group",
        "assessment",
        "reduction",
        "department",
        "measure",
        "care",
        "pharma",
        "molnupiravir",
        "reporting",
        "bengaluru",
        "michael",
        "jersey",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}